Modulating effect of Liv.100, an ayurvedic formulation on antituberculosis drug-induced alterations in rat liver microsomes
| Autor: | C. S. Shyamala Devi, S. D. Saraswathy |
|---|---|
| Rok vydání: | 2001 |
| Předmět: |
Male
Herbal Medicine Antitubercular Agents India Ascorbic Acid Pharmacology Pharmacognosy Protective Agents law.invention Lipid peroxidation chemistry.chemical_compound Magnoliopsida Cytochrome P-450 Enzyme System Oral administration law Isoniazid Medicine Animals Drug Interactions Rats Wistar Cytochrome Reductases NADPH-Ferrihemoprotein Reductase Plants Medicinal business.industry Plant Extracts Pyrazinamide Cytochrome b Group Medicine Ayurvedic Rats chemistry Toxicity Glucose-6-Phosphatase Microsomes Liver Lipid Peroxidation Rifampin business Phytotherapy Rifampicin Cytochrome-B(5) Reductase medicine.drug |
| Zdroj: | Phytotherapy research : PTR. 15(6) |
| ISSN: | 0951-418X |
| Popis: | The influence of Liv.100 on the hepatotoxicity of antituberculosis drugs [isoniazid (INH), rifampicin (RMP) pyrazinamide (PZA)] was studied in male albino rats. INH, RMP, and PZA were proved to be the most hepatotoxic. Rats were treated with antituberculosis drugs daily for a period of 6 weeks by intragastric administration. The combined use of antituberculosis drugs elevated the levels of cytochrome P-450 and cytochrome-b5. A significant increase was observed in the levels of NADPH-cytochrome P-450 reductase and NADH-cytochrome-b5 reductases after antitubercular drug administration. During antitubercular drug treatment a significant decrease was also observed in the activity of glucose-6-phosphatase. The extent of NADPH-induced and ascorbic acid-induced lipid peroxides were marked in antitubercular drug treatment, when compared with normal control animals. Oral Liv.100 co-administration, for the same period, modulated the alterations in the xenobiotic metabolizing system and microsomal lipid peroxidation in experimental animals. The results are discussed with reference to drug metabolizing enzymes, lipid peroxidation and the hepatoprotective nature of Liv.100. Copyright © 2001 John Wiley & Sons, Ltd. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Plný text